Oncimmune LLC, provider of EarlyCDT-Lung, a simple physician-ordered blood test that aids physicians in the risk assessment and early detection of lung cancer in high-risk patients, most notably long-term smokers or former smokers, today announced that the test is now commercially available in Canada after receiving strong interest from Canadian physicians at the American Colle...